Progress of engineered bacteria for tumor therapy

Adv Drug Deliv Rev. 2022 Jun:185:114296. doi: 10.1016/j.addr.2022.114296. Epub 2022 Apr 16.

Abstract

Recently, with the rapid development of bioengineering technology and nanotechnology, natural bacteria were modified to change their physiological activities and therapeutic functions for improved therapeutic efficiency of diseases. These engineered bacteria were equipped to achieve directed genetic reprogramming, selective functional reorganization and precise spatio-temporal control. In this review, research progress in the basic modification methodologies of engineered bacteria were summarized, and representative researches about their therapeutic performances for tumor treatment were illustrated. Moreover, the strategies for the construction of engineered colonies based on engineering of individual bacteria were summarized, providing innovative ideas for complex functions and efficient anti-tumor treatment. Finally, current limitation and challenges of tumor therapy utilizing engineered bacteria were discussed.

Keywords: Bacterial community; Engineered bacteria; Synthetic biology; Therapeutic effect; Tumor therapy.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacteria* / genetics
  • Bioengineering
  • Humans
  • Neoplasms* / therapy